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Abstract
Dysfunction of b-cell is one of major characteristics in the pathogenesis of type 2 diabetes. The combination of obesity and
type 2 diabetes, characterized as ‘diabesity’, is associated with elevated plasma free fatty acids (FFAs). Oxidative stress has
been implicated in the pathogenesis of FFA-induced b-cell dysfunction. However, molecular mechanisms linking between
reactive oxygen species (ROS) and FFA-induced b-cell dysfunction and apoptosis are less clear. In the present study, we test
the hypothesis that NOX2-derived ROS may play a critical role in dysfunction and apoptosis of b-cells induced by FFA. Our
results show that palmitate and oleate (0.5 mmol/L, 48 h) induced JNK activation and AKT inhibition which resulted in
decreased phosphorylation of FOXO1 following nuclear localization and the nucleocytoplasmic translocation of PDX-1,
leading to the reducing of insulin and ultimately dysfunction of pancreatic NIT-1 cells. We also found that palmitate and
oleate stimulated apoptosis of NIT-1 cells through p38MAPK, p53 and NF-kB pathway. More interestingly, our data suggest
that suppression of NOX2 may restore FFA-induced dysfunction and apoptosis of NIT-1 cells. Our findings provide a new
insight of the NOX2 as a potential new therapeutic target for preservation of b-cell mass and function.
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Introduction
Type 2 diabetes is a multifactorial disease including genetic and
many other environmental factors. Dysfunction of b-cell is one of
major characteristics in the pathogenesis of type 2 diabetes [1].
The prevalence of obesity in a modern society has increased
dramatically over the past few years and has reached epidemic
proportions. The combination of obesity and type 2 diabetes,
characterized as ‘diabesity’, is associated with excessive release of
fatty acids from the expanded adipose tissue mass, leading to
elevated plasma free fatty acids (FFAs) [2].
Dysfunction of b-cell is induced by several molecules including
glucose, FFA, and certain cytokines such as TNF-a [3]. Elevated
plasma FFA levels, which are often accompanied by obesity, may
play a causal role in b-cell dysfunction. It is reported that acute
FFA exposure stimulates insulin secretion, while prolonged FFA
exposure decreases glucose-stimulated insulin secretion (GSIS)
[4,5]. However, molecular mechanisms linking FFA to b-cell
dysfunction remain poorly understood.
Oxidative stress has been implicated in the pathogenesis of FFA-
induced b-cell dysfunction. It has been suggested that increased
reactive oxygen species (ROS) levels are the important trigger for
b-cell dysfunction. Under diabetic conditions, ROS are increased
in many tissues and organs and cause various forms of tissue
damage in patients with diabetes. It is considered that enhanced
ROS generation may act as a link between FFA and b-cell
dysfunction [6].
We recently found that suppression of NADPH oxidase 2
(NOX2) substantially restores glucose-induced dysfunction of
pancreatic NIT-1 cells. Here, we demonstrate the critical role of
NOX2-derived ROS in dysfunction of NIT-1 cells treated with
palmitate or oleate. We show novel data that NOX2-derived ROS
may promote FFA-induced dysfunction of b-cell through JNK
pathway.
Results
Increased ROS generation in NIT-1 cells treated with
palmitate and oleate is mainly derived by NOX2
To observe effects of FFA on ROS production in pancreatic b-
cells, mouse pancreatic NIT-1 cells were treated with different
concentrations of palmitate or oleate (0.15, 0.25, 0.5 mmol/L) for
different time (6, 12, 24, 48 h). As shown in Fig. 1A and Fig. 1B,
ROS levels were dose- and time-dependently increased by
exposure of NIT-1 cells to palmitate and oleate. In order to
further assess the source of ROS production, we investigated the
effects of different inhibitors of ROS-generating systems: DPI
(NOX, 2.5 mmol/L), L-NAME (nitric oxide synthases, 50 mmol/
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15726L), Rotenone (mitochondrial respiratory chain, 1 mmol/L) and
Oxypurinol (xanthine oxidase, 50 mmol/L) on palmitate- and
oleate-induced increased ROS levels. As shown in Fig. 1C, DPI
significantly and Rotenone partially, but not L-NAME and
Oxypurinol, inhibited generation of ROS in response to palmitate
and oleate (0.5 mmol/L, 48 h). These results suggest NOX as a
leading candidate for production of ROS in NIT-1 cells. Using




phox and Rac1—but not NOX1, NOX3,
NOX4 and NOX5— in NIT-1 cells (data not show). To further
assess the role of NOX2 in palmitate- and oleate-induced
increased ROS generation in NIT-1 cells, we generated the
siRNA targeting NOX2 mRNA (siRNA-NOX2) and transfected
them into NIT-1 cells. The results indicate that transfection of
siRNA-NOX2, but not control siRNA, significantly reduced ROS
generation in NIT-1 cells treated with either palmitate or oleate
(Fig. 1D), suggesting that NOX2 serves as the possible predominant
source of ROS generation stimulated by palmitate and oleate.
Treatment of palmitate and oleate induces dysfunction
and apoptosis in NIT-1 cells
Glucose-stimulated insulin secretion (GSIS) is the remarkable
character of b-cell. To analyze the effect of palmitate and oleate on
b-cell dysfunction, we determined the insulin expression and
secretion in NIT-1 cells exposure to either 0.5 mmol/L palmitate
or oleate for 48 h. ELISA showed unchanged basal (2.5 mmol/L
glucose in KRBH) insulin secretion and decreased glucose-
stimulated insulin secretion (GSIS; 20 mmol/L glucose in KRBH)
in NIT-1 cells in response to palmitate and oleate (Fig. 2A).
Moreover, mRNA levels of insulin were significantly reduced in
NIT-1 cells treated with palmitate and oleate, as shown by real-
time PCR (Fig. 2B), demonstrating that palmitate and oleate
induce dysfunction of NIT-1 cells.
We next investigated whether apoptosis occurs in the NIT-1
cells treated with palmitate and oleate. Using Annexin V and PI
kit, we found that NIT-1 cells treated with 0.5 mmol/L of
palmitate and oleate for 24 h were double-stained, suggesting that
palmitate and oleate induce apoptosis of NIT-1 cells (Fig. 2C).
Moreover, Oil Red O staining showed increased lipid accumu-
lation in NIT-1 cells treated with palmitate and oleate (Fig. 2D).
Palmitate and oleate impairs insulin synthesis in NIT-1
cells by PTEN-depend JNK activation and Akt inhibition
We then investigated what downstream pathways translate
palmitate- and oleate-induced elevated ROS levels into dysfunc-
tion of pancreatic b-cells. Here, we focus on PTEN-depend JNK
activation and Akt inhibition. As shown in Fig. 3, PTEN was
activated in response to palmitate and oleate treatment in NIT-1
cells. In parallel with increased phosphorylation of PTEN,
phosphorylation of the residue
183Thr/
185Tyr in JNK was
stimulated by palmitate and oleate treatment. Finally, exposure
to palmitate and oleate reduced the phosphorylation of Akt.
Western blot showed that FOXO1 content was decreased in
cytoplasm but increased in nucleus. In contrast, level of PDX-1
was increased in cytoplasm but decreased in nucleus (Fig. 3B).
Importantly, palmitate- and oleate-induced translocation of
FOXO1 and PDX-1 led to impaired insulin synthesis in NIT-1
cells.
Palmitate and oleate induces apoptosis in NIT-1 cells
through p38MAPK and p53
We next sought to determine the mechanisms behind the
apoptosis in b-cell induced by FFAs and to evaluate whether these
factors correlated to the oxidative stress and apoptosis. As shown
in Fig. 4A, exposure to palmitate and oleate for 48 h strongly
stimulated phosphorylation of p38 MAPK and p53. Moreover, we
found enhanced phosphorylation of I-kBi n
32Ser, followed by
degradation of I-kB, confirming NF-kB activation (Fig. 4B). The
results suggest that NF-kB is also involved in the procedure of
apoptosis of NIT-1 cells induced by palmitate and oleate.
We further assessed the molecules involved in FFA-induced
apoptosis. Bax as a key factor in the process of apoptosis was
measured by Western blot. Translocation of Bax into mitochon-
drial was found in NIT-1 cells treated with palmitate and oleate
(Fig. 4B). Moreover, palmitate and oleate stimulated increased
expression of cytochrome C and released it from mitochondrial to
cytoplasm (Fig. 4B and 4C). These observations indicate that
p38MAPK and p53 mediate the apoptosis of NIT-1 cells induced
by palmitate and oleate.
Suppression of NOX2 restores FFA-induced dysfunction
and apoptosis of NIT-cells
To verify the key role of NOX2 in the dysfunction and
apoptosis induced by palmitate and oleate, we transfected siRNA-
NOX2 into NIT-1 cells. The results show unchanged basal
(2.5 mmol/L glucose in KRBH) insulin secretion in NIT-1 cells
transfected with siRNA-NOX2. However, NOX2 down-regula-
tion reversed palmitate- and oleate-induced decreased glucose-
stimulated insulin secretion (GSIS; 20 mmol/L glucose in KRBH)
(Fig. 5A), increased JNK phosphorylation and decreased Akt
phosphorylation in NIT-1 cells (Fig. 5B). Moreover, effects of
palmitate and oleate on activation of p38MAPK and p53 were
rescued via siRNA-mediated silencing of NOX2 (Fig. 5C). These
results suggest that suppression of NOX2 may restore FFA-
induced dysfunction and apoptosis of NIT-1 cells.
Discussion
This study was designed to identify the mechanisms of
lipotoxicity in diabetes and to test the hypothesis that NOX2-
derived ROS may play a critical role in dysfunction and apoptosis
of b-cells induced by FFAs. The underlying concept is that once
the primary pathogenesis of diabetes is established, hyperglycemia
and very commonly hyperlipidemia ensue and thereafter exert
additional damaging or toxic effects on the b-cell [7]. It has been
suggested that insulin resistance precedes development of type 2
diabetes. A common feature of insulin resistant states is high
plasma FFA [8]. In addition to reducing insulin sensitivity in
peripheral tissues, elevated plasma FFA levels may also contribute
to the deterioration of b-cell function. A number of in vitro studies,
using insulin-secreting cells and isolated islets, have attempted to
identify the mechanisms of lipotoxicity in b-cell dysfunction. In
vitro, prolonged exposure of isolated islets or insulin-secreting cells
to elevated levels of FFAs is associated with inhibition of glucose-
induced insulin secretion [9,10] that has also been observed in vivo
in rats [11] and humans [12], impairment of insulin gene
expression [13–18] and induction of cell death by apoptosis
[19,20]. Accordingly, we stimulated pancreatic NIT-1 cells for
48 h with 0.5 mmol/L palmitate (a saturated fatty acid) and
0.5 mmol/L oleate (a -monounsaturated fatty acid). The results
indicate that palmitate and oleate induced apoptosis of NIT-1 cells
(Fig. 2C). Moreover, palmitate and oleate treatment decreased
glucose-induced insulin secretion, impaired insulin gene expres-
sion, and increased lipid accumulation in NIT-1 cells, suggesting a
state of b-cell dysfunction (Fig. 2A, 2B and 2D). Although it is
reported that palmitate induced b-cell apoptosis whereas oleate
protected NIT-1 cells from palmitate-induced lipoapoptosis [21], a
FFAs Induce Dysfunction and Apoptosis of b-Cells
PLoS ONE | www.plosone.org 2 December 2010 | Volume 5 | Issue 12 | e15726FFAs Induce Dysfunction and Apoptosis of b-Cells
PLoS ONE | www.plosone.org 3 December 2010 | Volume 5 | Issue 12 | e15726plethora of studies has indicated that chronic exposure of b-cell to
elevated levels of FFAs is accompanied by the loss of glucose-
stimulated insulin secretion (GSIS) and a decrease in total insulin
content [22]. Oleate has been shown to induce defects in GSIS in
numerous pancreatic b-cell lines as well as rodent and human islets
[23]. Recently, it has been suggested that chronic exposure of
human pancreatic islets to oleate activates inflammatory and
metabolic pathways that lead to oxidative stress, reduced b-cell
insulin content, and inhibition of GSIS [2]. Moreover, the study in
INS-1 demonstrated that exposure to oleate induced b-cell
apoptosis, as did palmitate [24,25]. Our results are consistent
with these findings.
What is the molecular link between FFAs and b-cell dysfunc-
tion? In view of the current weigh of experimental evidence, it is
now widely accepted that oxidative stress contribute to cell and
tissue dysfunction and damage caused by lipotoxicity in diabetes.
Recently, it has been also shown that chronic exposure to elevated
fatty acids concentrations can damage different types of cells by a
variety of mechanisms, but oxidative stress may be a common link
in cell dysfunction [26,27]. Increased FFAs metabolism may also
lead to increased ROS production. It has been reported that FFAs
initiates formation of ROS in pancreatic b-cells [28,29]. Our
results demonstrate that ROS levels were dose- and time-
dependently enhanced by exposure of NIT-1 cells to palmitate
and oleate (Fig. 1A and 1B). To further assess the source of ROS
generation in response to stimulation of palmitate and oleate, we
observed effects of different inhibitors of ROS-producing systems
such as mitochondrial electron transport chain, NOX, nitric oxide
synthase and xanthine oxidase. The results suggest that NOX may
be the predominant source of ROS in NIT-1 cells, although
Rotenone, a mitochondrial respiratory chain inhibitor, may
partially inhibit generation of ROS in response to palmitate and
oleate (Fig. 1C). The members of NOX family including NOX1,
NOX2, NOX3, NOX4 and NOX5 have been identified in
Figure 2. FFA- induced dysfunction and apoptosis of NIT-1 cells. Palmitate and oleate (0.5 mmol/L, 48 h) decreased glucose-stimulated
insulin secretion (GSIS, 20 mmol/L D-glucose in KRBH) (A), reduced insulin mRNA level shown by real-time PCR (B), induced apoptosis assessed by
double-staining with Annexin V and PI (C) and increased lipid accumulation detected by Oil Red O Staining in NIT-1 cells (D). Data are present as
mean 6 S.E.M., n=3 independent experiments. *p,0.05 and **p,0.01 by ANOVA test (Palmitate/Oleate v.s. control).
doi:10.1371/journal.pone.0015726.g002
Figure 1. FFA-induced increased ROS generation in NIT-1 cells. ROS levels were dose- and time-dependently increased by exposure of NIT-1
cells to palmitate and oleate (A, B). The effects of different inhibitors of ROS-generating systems: DPI (NOX, 2.5 mmol/L), L-NAME (nitric oxide
synthases, 50 mmol/L), Rotenone (mitochondrial respiratory chain, 1 mmol/L) and Oxypurinol (xanthine oxidase, 50 mmol/L) on palmitate- and oleate-
induced ROS generation were analyzed (C). NIT-1 cells were transiently transfected with siRNA-NOX2 for 48 h followed by palmitate and oleate
(0.5 mmol/L) treatment for 48 h, and ROS generation was measured (D). Data are present as mean 6 S.E.M., n=3 independent experiments. *p,0.05
and **p,0.01 by ANOVA test (Palmitate/Oleate v.s. control). {p,0.05 and {{p,0.01 by ANOVA test (siNOX2+Palmitate/Oleate v.s. Palmitate/Oleate).
doi:10.1371/journal.pone.0015726.g001
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enhanced the phosphorylation of PTEN and JNK, and reduced the phosphorylation of Akt (A). FOXO1 content was impaired in cytoplasm but
elevated in nucleus, while level of PDX-1 was increased in cytoplasm but decreased in nucleus (B). Data are present as mean 6 S.E.M., n=3
independent experiments. *p,0.05 and **p,0.01 by ANOVA test (Palmitate/Oleate v.s. control).
doi:10.1371/journal.pone.0015726.g003
Figure 4. Molecular mechanisms involved in apoptosis of b-cells induced by FFA. Palmitate and oleate (0.5 mmol/L, 48 h) stimulated the
phosphorylation of p53 and p38MAPK (A). Palmitate and oleate induced degradation of I-kB, phosphorylation of I-kBi n
32Ser (B), translocation of Bax
into mitochondrial (B), release and translocation of cytochrome C (B, C). Data are present as mean 6 S.E.M., n=3 independent experiments. *p,0.05
and **p,0.01 by ANOVA test (Palmitate/Oleate v.s. control).
doi:10.1371/journal.pone.0015726.g004
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and subunits such as p22
phox, p47
phox and p67
phox are expressed in
rat pancreatic islets [31]. We also found a similar expression
pattern of NOX and partners in NIT-1 cells (data not shown).
NOX2 down-regulation by transfection of siRNA-NOX2 reduced
ROS generation (Fig. 1D), and, in turn, improved the function in
NIT-1 cells treated with palmitate and oleate (Fig. 5), suggesting
that NOX2 may be a leading candidate for production of ROS in
NIT-1 cells. Recently, it was reported that NOX2 deficiency
decreases b-cell destruction and preserves islet function in STZ-
induced diabetes by reducing ROS production, immune response,
and b-cell apoptosis [31]. Our results confirm the findings of in vivo
study.
It is well known that excessive levels of ROS not only directly
damage cells by oxidizing DNA, protein and lipid, but also
indirectly damage cells by activating a variety of stress-sensitive
intracellular signaling pathways such as NF-kB, p38MAPK and
JNK/Akt [32,33]. In oxidative stress state, PTEN is phoshorylated
in
380Ser/
382/383Thr, leading to activation of JNK by phosphor-
ylation in
183Thr/
185Tyr and decreased phosphorylation of Akt
through increased PIP3 producing [34]. Activation of these
pathways results in increased expression of numerous gene
products that may cause apoptosis and play a major role in b-
cell dysfunction.
The mechanisms underlying the decrease in glucose-stimulated
insulin secretion by fatty acids are less clear, although recent
studies have provided important insights into potential candidates
such as G protein-coupled receptor GPR40 which may play a
major role in the deleterious effects of FFAs on b-cell function,
uncoupling protein-2 (UCP-2) which is suggested that UCP-2
modulates insulin secretion, and ATP-binding cassette transporter
subfamily A member-1 (ABCA1) which impairs insulin secretion
Figure 5. Suppression of NOX2 restores FFA-induced dysfunction and apoptosis of NIT-cells. NIT-1 cells were transiently transfected with
siRNA-NOX2 for 48 h followed by palmitate and oleate (0.5 mmol/L) treatment for 48 h. The release of insulin (A), expression of insulin and activation
of PTEN-JNK pathway (B), p38MAPK and p53 pathways (C) were measured. Data are present as mean 6 S.E.M., n=3 independent experiments.
*p,0.05 and **p,0.01 by ANOVA test (Palmitate/Oleate v.s. control). {p,0.05 and {{p,0.01 by ANOVA test (siNOX2+Palmitate/Oleate v.s. Palmitate/
Oleate).
doi:10.1371/journal.pone.0015726.g005
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candidates on FFA-induced b-cell dysfunction. Regarding FFA-
induced impairment of insulin gene expression in b-cell, we found
that reduction of insulin gene expression in NIT-1 cells exposed to
palmitate or oleate is accompanied by a decrease of PDX-1
expression in nuclei, suggesting the implication of PDX-1 in b-cell
dysfunction. PDX-1, a homeodomain-containing transcription
factor that plays a pivotal role in pancreatic development, b-cell
differentiation, and in maintaining mature b-cell function, is
reported to have a functional nuclear localization signal and
undergoes nuclear translocation in response to several functional
stimuli such as glucagon-like peptide-1 [35]. Conversely, in the
present study, we show that PDX-1 also possesses a nuclear export
signal in response to FFA. PDX-1 appears to be affected in its
ability of translocation to the nucleus. Thus, it is likely that
palmitate or oleate inhibition of insulin gene transcription is due to
nucleocytoplasmic translocation of PDX-1 and decreased binding
activity of PDX-1. More interestingly, palmitate- or oleate-induced
nucleocytoplasmic translocation of PDX-1 is accompanied by a
decrease in cytoplasm but an increase in nucleus of FOXO1
expression, suggesting that FOXO1 translocation might modulate
the decrease of PDX-1 in nucleus. It bas been demonstrated that
oxidative stress induces the nuclear translocation of FOXO1
through activation of the JNK pathway, which leads to the
nucleocytoplasmic translocation of PDX-1 [35]. FOXO1 is
reported to reduce PDX-1 promoter activity by competing with
Foxa2 for DNA binding to the PDX-1 promoter [36]. However,
function of FOXO1 in regulating intracellular localization of
PDX-1 might not be due to a transcriptional event, because whole
cell amount of PDX-1 was not altered by the modification of
FOXO1 expression by adenovirus [35]. Further studies need to be
performed to clarify the detailed mechanism underlying the
FOXO1-induced nucleocytoplasmic translocation of PDX-1. We
also found that phosphorylation of Akt was reduced in NIT-1 cells
treated with palmitate or oleate, suggesting that Akt is involved in
the FFA-mediated nuclear translocation of FOXO1. Moreover,
our findings suggest the involvement of the JNK-Akt- FOXO1-
PDX-1-insulin axis in the impairment of insulin expression, and
this pathway may explain parts of the molecular mechanisms of b-
cell dysfunction induced by FFAs. It has been reported that JNK
activation is involved in the reduction of insulin gene expression by
oxidative stress [37] and JNK activation induces the nucleocyto-
plasmic translocation of the pancreatic transcription factor PDX-1
and thereby reduces PDX-1 DNA binding activity [38]. In our
findings, elevated phosphorylation of JNK is accompanied by
reduced phosphorylation of Akt and FOXO1 in NIT-1 cells
treated with palmitate or oleate. In conclusion, FFA-induced JNK
activation and Akt inhibition resulted in decreased phosphoryla-
tion of FOXO1 following nuclear localization and the nucleocy-
toplasmic translocation of PDX-1, leading to the reducing of
insulin and ultimately dysfunction of b-cells.
Several pathways have been proposed to mediate FFAs-induced
apoptosis in b-cells, including p38MAPK, p53 and NF-kB
pathways. It has been reported that p38 MAPK is activated by
dual phosphorylation of
180Thr and
182Tyr residues, and p53 is
activated by
15Ser residues. The phosphorylation of p38 MAPK
and p53 has been widely used to represent its activation in
response to oxidative stress. Our results suggest that p38MAPK
and p53 mediated the apoptosis of NIT-1 cells induced by
palmitate or oleate. Exposure of palmitate or oleate for 48 h
strongly stimulated phosphorylation of p38MAPK and p53,
accompanied by activation of NF-kB. NF-kB activation is pro-
apoptotic in pancreatic b-cells. FFAs are able to activate NF-kB.
NF-kB activation mediates expression of inflammatory genes, in
term induces cell apoptosis. Moreover, It bas been suggested that
NF-kB is involved in the procedure of apoptosis mediated by p53
[39].
In addition, JNK activation is known to induce cell apoptosis.
Some transcription factors including c-Jun, ATF2, Elk1, c-myc, or
p53 are major targets of JNK. Thus, JNK activation probably acts
by modifying the expression of genes that play an important role in
controlling cell death or survival. Therefore, the coordinate
regulation of the genes controlled by JNK sensitizes b-cells to
the proapoptotic action of FFAs [39].
Moreover, translocation of Bax into mitochondrial was found in
NIT-1 cells treated with palmitate and oleate. Palmitate and oleate
also increased expression of cytochrome C and released it from
mitochondrial to cytoplasm. In addition, it has been shown that
FFAs might contribute to b-cell apoptosis by decreasing insulin/
Akt signaling [32,33]. As a proapoptotic transcription factor,
FOXO1 is also involved in b-cell apoptosis induced by FFAs [39].
More interestingly, our data suggest that suppression of NOX2
may restore FFA-induced dysfunction and apoptosis of NIT-1
cells. Our findings provide a new insight of the NOX2 as a




NIT-1 cells derived from mouse pancreatic b-cells (ATCC, 20–
30 passages) were cultured in low-glucose DMEM (5 mmol/L
glucose, Gibco) supplements with 10% fetal bovine serum
(Hyclone), 100 U/ml penicillin (Gibco) and 0.1 mg/ml strepto-




5 cells/ml) were incubated with 5 mmol/L of DCF-
DA (Sigma) for 40 min at 37uC. The DCF fluorescence was
measured by FACS with an excitation/emission wavelength of
488/525 nm.
RNA isolation, RT-PCR and real-time PCR
Total RNA was isolated from NIT-1 cells using the Trizol
Regent (Invitrogen). Reverse transcription (RT) was performed on
1 mg RNA at 60uC for 35 min using a Reverse Transcription kit
(A3500, Promage) containing 0.5 mg random primers, 15 U AMV,
0.5 U RNasin RNase inhibitor. After reverse transcription, the
cDNAs were used for semi-quantitative PCR using sets of specific
primers as follows:
NOX1: 59-GAAATTCTTGGGACTGCCTTGG-39 and 59-
GCTGGAGAGAACAGAAGCGAGA-39;




NOX4: 59-GGACGTCCTGGTGGAAACTT-39 and 59-
GCAAACCCTTGGGTATTCTTTGG-39;
P22 phox: 59-GGAGCGATGTGGACAGAAGTA-39 and 59-
GCACCGACAACAGGAAGTG-39;
p47 phox: 59-’CTATCTGGAGCCCCTTGACA-39 and 59-
ACAGGGACATCTCGTCCTCTT-39;
p67 phox: 59-CCAGAAGACCTGGAATTTGTG-39 and 59-
AAATGCCAACTTTCCCTTTACA-39;
Rac-1: 59-AGACAATTTGGGCACACCTC-39 and 59-
GCTTCGTCA AACACTGTCTTG-39;
FFAs Induce Dysfunction and Apoptosis of b-Cells
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CTCCTTAATGTCACGCACGATTTC-39.
An initial step of 94uC was used for 5 min followed by 30 cycles
of 94uC for 1 min, 60uC for 1 min, and 72uC for 1 min. RT-PCR
was finished with 72uC for 7 min. Fifteen micro liters of reaction
were run on a 1.5% agarose gel and photographed on a UV
transilluminator using a digital camera.
Real-time PCR was performed using A7500 Real-Time Ther-
mal Cycler (ABI). The specific primers for real-time PCR are: 59-
CTTCTACACACCCAAGTCCCG-39 and 59-GTGCAGCAT-
GATCCACAATG-39 for insulin; 59-CGTCCCGTAGACAAA-
ATGGT-39 and 59-TTGATGGCAACAATCTCCAC-39 for GA-
PDH. Amplification was carried out as recommended by the
manufacturer: 25 ml reaction mixture contained 12.5 ml of SYBR
Green PCR Master mix (Applied Biosystems), the appropriate
primer concentration, and 1 ml of cDNA. The relative cDNA
concentrations were established by a standard curve using
sequential dilutions of corresponding PCR fragments. The data
were normalized to GAPDH. The amplification program included
the initial denaturation step at 95uC for 10 min, 40 cycles of
denaturation at 95uC for 10 s, and annealing and extension at
60uC for 1 min. Fluorescence was measured at the end of each
extension step. After amplification, melting curves were acquired
and used to determine the specificity of PCR products.
Determination of apoptosis
To determine apoptosis in INT-1cells, cells were double-stained
with Annexin V and PI kit (Baosai) according to the manufactur-
er’s protocol. Stained nuclei were immediately visualized by
fluorescence microscopy.
Oil Red O staining
After incubation in the presence or absence of palmitate or
oleate for 48 h, confluent cell monolayer was fixed in phosphate-
buffered formalin (10%) for 15 min, rinsed with water followed by
70% ethanol, and stained with Oil Red O solution (6 parts of
saturated Oil Red O dye in isopropanol +4 parts of water) for
15 min. Excess stain was removed by washing with 70% ethanol.
The stained cells were finally washed with water. The cell
monolayer was then incubated for 5 min with 1.5 ml of 4%
Nonidet P-40 in isopropanol which dissolved stained oil droplets.
The absorbance of the dye-triglyceride complex was measured at
520 nm after suitable dilution.
Immunofluorescence
The coverslips of NIT-1 cells were fixed for 10 min with ice-
cold methonal at 220uC. The cells were incubated with polyclonal
antibodies at 4uC overnight, and then were labeled with
Fluorescein Isothiocyanate (FITC)-conjugated anti-rabbit IgG at
37uC for 60 min and stained with DAPI at room temperature for
2 min. Finally, the coverslips were mounted with DABCO.
Measurement of insulin secretion
NIT-1 cells were washed with a modified Krebs-Ringer/
bicarbonate-HEPES buffer (KRBH, 140 mmol/L NaCl,
3.6 mmol/L KCl, 0.5 mmol/L NaH2PO4, 0.5 mmol/L MgSO4,
1.5 mmol/L CaCl2, 2 mmol/L NaHCO3, 10 mmol/L HEPES,
0.1% BSA, pH7.4) and pre-equilibrated with DMEM containing
2.5 mmol/L glucose for 5 h at 37uC. Cells were then incubated
for 35 min in KRBH buffer containing 2.5 mmol/L glucose (basal
secretion) or KRBH buffer containing 20 mmol/L glucose
(glucose-stimulated insulin secretion, GSIS). Incubates were
collected and frozen for insulin assays [40,41]. Insulin was
determined by an ELISA kit (Linco) according to the manufac-
turer’s protocol.
siRNA transfection
The siRNAs targeting the mouse NOX2 or PTEN mRNA were
transfected into NIT-1 cells using Tran Messenger TM Transfec-
tion Reagent (Qiagen) according to manufacture’s instruction. A
luciferase siRNA (FAM) was used as a negative control. RNAi
oligonucleotides for transfection are 59-UGCCAGAGUCGG-
GAUUUCU-39dTdT for NOX2; 59-GTATAGAGCGTGCA-
GATAA-39dTdT for PTEN; 59-UUCUCCGAACGUGUCACG
-39dTdT for FAM.
Protein preparation of whole cell, nuclei, cytoplasm and
mitochondrial fractions respectively
NIT-1 cells were lysed in a lysis buffer containing 50 mmol/l
Tris-HCl (PH 8.0), 150 mol/l NaCl, 0.02% NaN3, 0.1% SDS,
1% NP-40, 100 mg/ml PMSF, 1 mg/ml aprotinin, 0.5% Sodium
deoxycholate supplemented with a phosphatase inhibitor cocktail
1 and 2 (Sigma) and sonicated for 2 s to shear DNA. Cell lysates
were centrifuged at 12,000 g for 10 min. Supernatant was used for
Western blot analysis.
Proteins of nuclei and cytoplasm fraction in NIT-1 cells were
prepared as previously described [35]. Briefly, the cells were
collected and centrifuged for 20 s in a microcentrifuge followed by
resuspending in Buffer 1 containing 10.0 mmol/L Hepes (pH 7.9),
10.0 mmol/L KCl, 1.5 mmol/L MgCl2 and 0.5 mmol/L dithio-
threitol. After incubation at 4uC for 15 min, the cells were lysed by
a Dounce homogenizer. The suspension was centrifuged for 20 s
in a microcentrifuge. And subsequently, the supernatant (cyto-
plasm fraction) was collected and frozen. The pellet, which
contained the nuclei, was resuspended in 150 ml Buffer 2
containing 20 mmol/L Hepes (pH 7.9), 20% v/v glycerol,
0.1 mol/L KCl, 0.2 mmol/L EDTA(PH 8.0), 0.5 mmol/L di-
thiothreitol and 0.5 mmol/L phenylmethanesulfonyl fluoride.
Having been stirred at 4uC for 30 min, the nuclear extracts were
centrifuged for 20 min at 4uC in a microcentrifuge. The
supernatant was collected and stored at 280uC.
Proteins of mitochondrial in NIT-1 cells were prepared as
previously described [42]. Briefly, the cells were collected and
lysed on ice for 30 min in buffer A containing 20 mmol/L Hepes-
KOH(PH 7.5), 10 mmol/L KCl, 1.5 mmol/L MgCl2, 1 mmol/L
EGTA, 1 mmol/L EDTA (PH 8.0), 1 mmol/L dithiothrei-
tol, 0.1 mmol/L PMSF, 1 mg/ml aprotinin and 250 mmol/L
sucrose. After a consecutive centrifugation at 1,000 g for 5 min
and 10,000 g for 15 min, the pellet, which contained mito-
chondrial fraction, was resuspended in buffer A and centrifuged at
100,000 g for 1 h. The supernatant was collected and stored at
280uC.
Western blot analysis
Cell lysates (10–30 mg protein) were separated by 10% or 15%
(for measuring insulin) SDS-PAGE, transferred to PVDF mem-
brane (Millipore, pore size 0.20 mm), blocked with 5% nonfat dry
milk for 60 min, and probed with antibodies at 4uC overnight.
The blots were incubated with Horseradish peroxidase (HRP)-
conjugated anti-IgG, followed by detection with ECL (Santa
Cruz). Antibodies to p38MAPK, phosphor-p38MAPK, JNK,
phosphor-JNK, Akt, phosphor-Akt, phosphor-p53, PTEN and
phosphor-PTEN were purchased from Cell Signaling. Antibodies
to I-kB, phosphor-I-kB, Bax, cytochrome C, HSP 70, p53,
FOXO1, PDX-1, insulin and b-actin were obtained from Santa
Cruz.
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All values are represented as means6SEM of the indicated
number of measurements. One-way ANOVA test was used to
determine significance, requiring p,0.05 for statistical significance.
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